CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.63 Cr | ₹-2.23 Cr | ₹-13 Cr | ₹-14 Cr | ₹-6.21 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹4.63 Cr |
| Mar2025 | ₹-2.23 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-14 Cr |
| Mar2022 | ₹-6.21 Cr |
How is Deferred Tax Assets / Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.63 Cr | Positive | |
| Mar2025 | ₹-2.23 Cr | Negative | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-14 Cr | Negative | |
| Mar2022 | ₹-6.21 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹19,008.0 Cr | 3.7% | -4% | 18.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 3.7% |
-4% |
18.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses